Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;49(2):369-370.
doi: 10.1007/s15010-020-01519-z. Epub 2020 Oct 19.

DGI recommendations for COVID-19 pharmacotherapy

Jakob J Malin  1   2 , Christoph D Spinner  3 ; German Society of Infectious Diseases (DGI)
Affiliations

DGI recommendations for COVID-19 pharmacotherapy

Jakob J Malin et al. Infection. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JJM reports no conflicts of interest. CDS reports grants and personal fees from Gilead Sciences, during remdesivir studies. Personal fees from AbbVie, grants and personal fees from Janssen-Cilag, MSD, GSK/ViiV, Grants from Lilly and Selinexor, outside remdesivir studies.

References

    1. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of COVID-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2007764. - DOI - PubMed
    1. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. - DOI - PMC - PubMed
    1. EMA. Veklury (remdesivir). An overview of Veklury and why it is authorised in the EU. https://www.ema.europa.eu/documents/overview/veklury-epar-medicine-overv.... Accessed 20 July 2020
    1. FDA emergency use authorization. U.S. Food and Drug Administration. https://www.fda.gov/media/137564/download. Accessed 27 May 2020.
    1. Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020;395:1569–1578. doi: 10.1016/s0140-6736(20)31022-9. - DOI - PMC - PubMed

LinkOut - more resources